4Ellen Phelps, Peiqing Wu, James Breiz, et al. Thyroid cell apoptosis - A new understanding of thyroid autoimmunity. Endocrinol Metab Clin North Am. 2000,29(2) :375.
5Kawakami A, Eguchi K, Matsuoka N, et al. Modulation of Fas- mediated apoptosis of human thyroid epithelial cells by IgG from patients with Graves' disease (GD) and idiopathic myxoedema. Clin Exp Immunol.1997, 110(3) :434.
6Shimaoka Y, Hidak Y, Okumura M, et al. Serum concentration of soluble Fas in patients with autoimmune thyroid disease. Thyroid. 1998,8(1):43.
7Hiromatsu Y, Bednarczuk T, Soyejima E,et al. Increased serum soluble Fas in patients with Graves' Disease.Thyroid. 1999, 9(4) :341.
8Wang CY, Zhong WB, Chang TC, et al. Circulating soluble Fas ligand correlates with disease activity in Graves' hyperthyroidism. Metabolism. 2002, 51(6) :769.
9Nagata S, Golstein P. The Fas death factor. Science, 1995, 267:1449.
10Kayanagi N, Kawasaki A, Ebata T, et al. Metallaproteinase - mediated release of human Fas ligand. J Exp Med. 1995, 182(6):1777.
